Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol + Bevacizumab in Wet AMD
NCT03609307Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of propranolol in exudative macular degeneration, sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
propranolol
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on NCT03609307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03609307.